published in The Lancet Regional Health – Western Pacific1 reported that the use of real-time continuous glucose monitoring (CGM) in hospitalised patients with diabetes receiving short-term continuous subcutaneous insulin infusion resulted in better glucose control compared to the present standard point-of-care (POC). This evidence concerns the gene INS and diabetes mellitus.